Log in

Relevant bibliographies by topics / NABPM / Journal articles

To see the other types of publications on this topic, follow the link: NABPM.

Journal articles on the topic 'NABPM'

Author: Grafiati

Published: 5 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'NABPM.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sobieraj, Piotr, Mateusz Lesniewski, Maciej Sinski, and Jacek Lewandowski. "THE AGREEMENT BETWEEN HEART RATE MEASURED USING UNATTENDED AUTOMATED BLOOD PRESSURE MEASUREMENT AND OTHER METHODS OF BLOOD PRESSURE ASSESSMENT." Journal of Hypertension 42, Suppl 1 (2024): e70. http://dx.doi.org/10.1097/01.hjh.0001019944.88639.89.

Full text

Abstract:

Objective: The trial was aimed to assess the agreement between resting heart rate (HR) measured using unattended automatic (uAOBPM) and office (OBPM) or 24-h ambulatory blood pressure measurement (ABPM). Design and method: A total of 110 participants were included in the study. All underwent measurements using uAOBPM, OBPM, and ABPM. Results of ABPM were analysed in 3 periods: 24h (24h-ABPM), day activity (aABPM) and night rest (nABPM). Continuous variables were presented as means with standard deviation, while categorical variables were expressed as numbers and percentages. The comparisons we

APA, Harvard, Vancouver, ISO, and other styles

2

Elmukhtar Habas, Kalifa Farfar, Ala Habas, et al. "BP measurement techniques: Clinical review and update." GSC Advanced Research and Reviews 13, no. 1 (2022): 067–76. http://dx.doi.org/10.30574/gscarr.2022.13.1.0270.

Full text

Abstract:

Increased blood pressure (BP) damages multiple organs. Diagnosis, treatment, and prevention of end-organ require regular, accurate BP measurement. BP was predominantly recorded using the mercury-based-sphygmomanometer. Recently, oscillometric-based devices have been invented and are commonly used worldwide. BP measurement methods are broadly divided into Office-based and out-of-clinic (home). The patient at home or workplace conducts home BP measurement, either intermittently (Non-ambulatory BP monitoring [NABPM]) or continuously (Ambulatory BP Monitoring [ABPM]). Despite the variety of BP mea

APA, Harvard, Vancouver, ISO, and other styles

3

Elmukhtar, Habas, Farfar Kalifa, Habas Ala, et al. "BP measurement techniques: Clinical review and update." GSC Advanced Research and Reviews 13, no. 1 (2022): 067–76. https://doi.org/10.5281/zenodo.7664949.

Full text

Abstract:

Increased blood pressure (BP) damages multiple organs. Diagnosis, treatment, and prevention of end-organ require regular, accurate BP measurement. BP was predominantly recorded using the mercury-based-sphygmomanometer. Recently, oscillometric-based devices have been invented and are commonly used worldwide. BP measurement methods are broadly divided into Office-based and out-of-clinic (home). The patient at home or workplace conducts home BP measurement, either intermittently (Non-ambulatory BP monitoring [NABPM]) or continuously (Ambulatory BP Monitoring [ABPM]). Despite the variety of BP mea

APA, Harvard, Vancouver, ISO, and other styles

4

Holl, Eda K., Victoria Frazier, David Boczkowski, Bruce Sullenger, and Smita K. Nair. "Targeting inflammation to prevent breast cancer metastasis." Journal of Immunology 200, no. 1_Supplement (2018): 178.25. http://dx.doi.org/10.4049/jimmunol.200.supp.178.25.

Full text

Abstract:

Abstract Biomarkers associated with systemic inflammation correlate with poor prognosis in cancer patients. Circulating cell-free DNA (cfDNA) is released passively and actively by both tumor cells and host cells and cfDNA levels in blood correlate with tumor burden in many tumor types. Notably, studies in breast cancer have shown that inhibition of cfDNA has a significant effect in reducing invasion and migration in vitro. We have previously demonstrated the ability of nucleic acid binding polymers (NABPs) to bind and inhibit the pro-inflammatory effects of cfDNA and RNA in models of systemic

APA, Harvard, Vancouver, ISO, and other styles

5

Kang, Hong Soon, Ju Youn Beak, Yong-Sik Kim та ін. "NABP1, a novel RORγ-regulated gene encoding a single-stranded nucleic-acid-binding protein". Biochemical Journal 397, № 1 (2006): 89–99. http://dx.doi.org/10.1042/bj20051781.

Full text

Abstract:

RORγ2 (retinoid-related orphan receptor γ2) plays a critical role in the regulation of thymopoiesis. Microarray analysis was performed in order to uncover differences in gene expression between thymocytes of wild-type and RORγ−/− mice. This analysis identified a novel gene encoding a 22 kDa protein, referred to as NABP1 (nucleic-acid-binding protein 1). This subsequently led to the identification of an additional protein, closely related to NABP1, designated NABP2. Both proteins contain an OB (oligonucleotide/oligosaccharide binding) motif at their N-terminus. This motif is highly conserved be

APA, Harvard, Vancouver, ISO, and other styles

6

Frazier, Victoria N., Eda Holl, David Boczkowski, Bruce Sullenger, and Smita K. Nair. "Targeting DAMP-induced inflammation to prevent breast cancer metastasis and improve anti-tumor immunity." Journal of Immunology 202, no. 1_Supplement (2019): 136.9. http://dx.doi.org/10.4049/jimmunol.202.supp.136.9.

Full text

Abstract:

Abstract Biomarkers associated with systemic inflammation correlate with poor prognosis in cancer patients. Circulating cell-free DNA (cfDNA) is released passively and actively by both tumor cells and host cells and cfDNA levels in blood correlate with tumor burden in many tumor types. Notably, studies in breast cancer have shown that inhibition of cfDNA has a significant effect in reducing invasion and migration in vitro and metastatic disease in vivo. We have previously demonstrated that nucleic acid binding polymers (NABPs) bind and inhibit the proinflammatory effects of cfDNA in a murine m

APA, Harvard, Vancouver, ISO, and other styles

7

Vidhyasagar, Venkatasubramanian, Yujiong He, Manhong Guo, et al. "C-termini are essential and distinct for nucleic acid binding of human NABP1 and NABP2." Biochimica et Biophysica Acta (BBA) - General Subjects 1860, no. 2 (2016): 371–83. http://dx.doi.org/10.1016/j.bbagen.2015.11.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Shi, Wei, Therese Vu, Glen Boyle, et al. "SSB1/NABP2 and SSB2/NABP1 Have Essential and Overlapping Roles in Maintaining Hematopoietic Stem and Progenitor Cells." Blood 126, no. 23 (2015): 2405. http://dx.doi.org/10.1182/blood.v126.23.2405.2405.

Full text

Abstract:

Abstract Single-stranded DNA binding (SSB) proteins are essential for a variety of DNA metabolic processes and the maintenance of genomic stability. SSB1 and its homolog SSB2, share greater sequence and domain homology to the archaeal and bacterial SSBs than eukaryotic RPA. They form complexes with two other proteins, C9Orf80 and INTS3, and play roles in mediating transcription and DNA repair. SSB1 (also known as OBFC2B or NABP2) is recurrently mutated in various cancers, however the precise function in normal development is incompletely understood. We have previously shown that Ssb1 is requir

APA, Harvard, Vancouver, ISO, and other styles

9

Miles, Carl J., and Min Zhou. "Determination of Nabam Fungicide in Crops by Liquid Chromatography with Postcolumn Reaction Detection." Journal of AOAC INTERNATIONAL 74, no. 2 (1991): 384–88. http://dx.doi.org/10.1093/jaoac/74.2.384.

Full text

Abstract:

Abstract The ethyleneblsdlthlocarbamate (EBDC) fungicide, nabam, was determined In several crop matrixes using liquid chromatography with postcolumn reaction detection. After separation by mlcellar liquid chromatography, nabam (EBDC sodium salt) was acid hydrolyzed to ethylenedlamlne and fluorogenlcally labeled with o-phthalaldehyde-mercaptoethanol (OPA-MERC). Standard curves were linear from the detection limit of ca 1 ng to 1000 ng. Nabam was recovered In high yield (89 ±7.7%) over a range of concentrations (0.1 to 20 ppm) from fortified samples of papaya, lettuce, cucumber, spinach, and app

APA, Harvard, Vancouver, ISO, and other styles

10

Tsubokawa, H., K. Oguro, T. Masuzawa, T. Nakaima, and N. Kawai. "Effects of a spider toxin and its analogue on glutamate-activated currents in the hippocampal CA1 neuron after ischemia." Journal of Neurophysiology 74, no. 1 (1995): 218–25. http://dx.doi.org/10.1152/jn.1995.74.1.218.

Full text

Abstract:

1. We studied the effects of polyamine toxins derived from a spider venom on CA1 pyramidal neurons in gerbil hippocampal slices by patch-clamp recording. Joro spider toxin (JSTX) and its synthetic analogue, 1-naphthyl acetyl spermine (Naspm), which are known to block non-N-methyl-D-aspartate (non-NMDA) receptor in a subunit specific manner, were used. 2. Naspm depressed the excitatory postsynaptic currents (EPSCs) mediated by non-NMDA receptor channels. A further reduction of EPSCs occurred with addition of 6-cyano-7-nitroquin-oxaline-2,3- dione (CNQX). Conversely, when CNQX was applied first,

APA, Harvard, Vancouver, ISO, and other styles

11

Fadzlina, Z. A. Noor, T. T. Teng, and M. Abdul Rahman. "Measurement and Prediction of Densities of Ternary Aqueous Mixtures Involving Sodium Polyacrylate." ASEAN Journal of Chemical Engineering 4, no. 1 (2004): 64. http://dx.doi.org/10.22146/ajche.50851.

Full text

Abstract:

The densities of the binary aqueous solutions of sodium polyacrylate (NaPM) at 20°C, 25°C, and 300C up to 0.17 m and LiCI at 25°C and 300C up to 3.13 m were measured using a vibrating tube digital densitimeter. The measured experimental data were then fitted to the polynomial d = do + IA;m'. The densities of the ternary aqueous systems NaPM-NaCI, NaPM-LiCI, and NaPM-sucrose were also =1 measured from 20°C to 30°C. The isopycnotic equation, Imi / moi was used to predict the densities of the ternary aqueous systems mentioned. The results show that predicted and observed density values are in goo

APA, Harvard, Vancouver, ISO, and other styles

12

Dhamija, Kriti, Kojo-Frimpong B. Awuah, Alexander Marwaha, Harmeet Kharoud, and Dulabh K. Monga. "Neoadjuvant therapy in borderline resectable and resectable pancreatic cancer." Journal of Clinical Oncology 43, no. 4_suppl (2025): 735. https://doi.org/10.1200/jco.2025.43.4_suppl.735.

Full text

Abstract:

735 Background: To improve clinical outcomes in borderline resectable and resectable pancreatic cancer patients, preoperative chemotherapy with or without radiation can be administered. According to NCCN, there is limited evidence to recommend a specific neoadjuvant chemotherapy regimen. The Dutch randomized phase III PREOPANC trial showed that preoperative chemoradiotherapy led to improved disease free survival. We compared overall survival (OS) between two chemotherapy regimens; mFOLFIRINOX (mFOL) and Gemcitabine/nabPaclitaxel (Gem/nabP). Methods: We performed a retrospective analysis of bio

APA, Harvard, Vancouver, ISO, and other styles

13

Saxena, Ashish, Paul J. Christos, Jennifer M. Cagney, and Ronald J. Scheff. "Retrospective analysis of nanoparticle albumin-bound paclitaxel (nabP) administered as a single agent in the treatment of recurrent stage IV (st4) non-small cell lung cancer (NSCLC)." Journal of Clinical Oncology 30, no. 15_suppl (2012): e18029-e18029. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e18029.

Full text

Abstract:

e18029 Background: NabP is a formulation of P designed to reduce toxicity of therapy and increase drug delivery to tumor cells. An established therapy for st4 breast cancer, single-agent nabP has also been shown to produce responses in frontline therapy of st4 NSCLC. Its role in relapsed NSCLC has not been well reported. Methods: We analyzed the records of st4 NSCLC patients (pts) treated with single-agent nabP at our institution. Cases were assessed with regard to age, sex, KPS, histology, line of systemic therapy, prior taxane exposure, # of cycles administered, dose attenuation, and progres

APA, Harvard, Vancouver, ISO, and other styles

14

Ramanathan, Ramesh K., Peter Lee, John E. Seng, et al. "Phase II study of induction therapy with gemcitabine and nab-paclitaxel followed by consolidation with mFOLFIRINOX in patients with metastatic pancreatic cancer." Journal of Clinical Oncology 32, no. 3_suppl (2014): 224. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.224.

Full text

Abstract:

224 Background: FOLFIRINOX or NabP-Gem are now standard mPC regimens.The optimal sequence is not known.This phase II study evaluated the feasibility of NabP-Gem followed by FOLFIRINOX. Methods: Eligible pts had evidence of untreated mPC, ECOG 0-1 and adequate organ function. Pts received Nab-P (125 mg/m2) and Gem (1000 mg/ m2) weekly x 3 (Induction ) every 4 weeks for upto 6 cycles. FOLFIRINOX, q2 weeks (Consolidation regimen) was initiated after 6 cycles of the Induction regimen, or earlier in case of progression, and given for a maximum of 6 months (12 cycles). mFOLFIRINOX (NEJM, 364:1817-25

APA, Harvard, Vancouver, ISO, and other styles

15

O'Reilly, Eileen Mary, Davide Melisi, Teresa Macarulla, et al. "Liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): 12- and 18-month survival rates from the phase 3 NAPOLI 3 trial." Journal of Clinical Oncology 41, no. 16_suppl (2023): 4006. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.4006.

Full text

Abstract:

4006 Background: Liposomal irinotecan + 5-fluorouracil/leucovorin (5-FU/LV) is approved in the USA and Europe for mPDAC following progression with gemcitabine-based therapy. A phase 1/2 study (NCT02551991) demonstrated promising anti-tumor activity in patients with mPDAC who received first-line liposomal irinotecan 50 mg/m2 + 5-FU 2400 mg/m2 + LV 400 mg/m2 + oxaliplatin 60 mg/m2 (NALIRIFOX). Here, we present results from NAPOLI 3 (NCT04083235), a randomized, open-label, phase 3 study investigating the efficacy and safety of NALIRIFOX compared with nab-paclitaxel 125 mg/m2 + gemcitabine 1000 mg

APA, Harvard, Vancouver, ISO, and other styles

16

He, Zhen, Haifeng Gan, and Xinyan Liang. "Analysis of Synonymous Codon Usage Bias in Potato Virus M and Its Adaption to Hosts." Viruses 11, no. 8 (2019): 752. http://dx.doi.org/10.3390/v11080752.

Full text

Abstract:

Potato virus M (PVM) is a member of the genus Carlavirus of the family Betaflexviridae and causes large economic losses of nightshade crops. Several previous studies have elucidated the population structure, evolutionary timescale and adaptive evolution of PVM. However, the synonymous codon usage pattern of PVM remains unclear. In this study, we performed comprehensive analyses of the codon usage and composition of PVM based on 152 nucleotide sequences of the coat protein (CP) gene and 125 sequences of the cysteine-rich nucleic acid binding protein (NABP) gene. We observed that the PVM CP and

APA, Harvard, Vancouver, ISO, and other styles

17

Nichetti, Federico, Simone Rota, Paolo Ambrosini, et al. "NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer." JAMA Network Open 7, no. 1 (2024): e2350756. http://dx.doi.org/10.1001/jamanetworkopen.2023.50756.

Full text

Abstract:

ImportanceThe NAPOLI 3 trial showed the superiority of fluorouracil, leucovorin, liposomal irinotecan, and oxaliplatin (NALIRIFOX) over the combination of gemcitabine and nab-paclitaxel (GEM-NABP) as first-line treatment of metastatic pancreatic ductal adenocarcinoma (PDAC). Analyses comparing NALIRIFOX and GEM-NABP with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) have not yet been reported.ObjectiveTo derive survival, response, and toxic effects data from phase 3 clinical trials and compare NALIRIFOX, FOLFIRINOX, and GEM-NABP.Data SourcesAfter a systematic search of Pub

APA, Harvard, Vancouver, ISO, and other styles

18

Traynor, Kate. "NABP to inspect compounding pharmacies." American Journal of Health-System Pharmacy 70, no. 2 (2013): 88–90. http://dx.doi.org/10.2146/news130006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Dalmat, Yann-Mickael. "La rougeole à la NABM." Option/Bio 31, no. 611-612 (2020): 9. http://dx.doi.org/10.1016/s0992-5945(20)30043-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Khoury, Marc A., Mohamad-Ali Bahsoun, Ayad Fadhel, et al. "Delusional Severity Is Associated with Abnormal Texture in FLAIR MRI." Brain Sciences 12, no. 5 (2022): 600. http://dx.doi.org/10.3390/brainsci12050600.

Full text

Abstract:

Background: This study examines the relationship between delusional severity in cognitively impaired adults with automatically computed volume and texture biomarkers from the Normal Appearing Brain Matter (NABM) in FLAIR MRI. Methods: Patients with mild cognitive impairment (MCI, n = 24) and Alzheimer’s Disease (AD, n = 18) with delusions of varying severities based on Neuropsychiatric Inventory-Questionnaire (NPI-Q) (1—mild, 2—moderate, 3—severe) from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) were analyzed for this task. The NABM region, which is gray matter (GM) and white matter

APA, Harvard, Vancouver, ISO, and other styles

21

Cen, Putao, Kok Hoe Chan, Curtis Jackson Wray, Nirav Thosani, John Bynon, and Julie Haewon Rowe. "Efficacy of sequential perioperative FOLFIRNOX plus gemcitabine nab-paclitaxel for resected pancreatic and periampullary cancers." Journal of Clinical Oncology 41, no. 4_suppl (2023): 724. http://dx.doi.org/10.1200/jco.2023.41.4_suppl.724.

Full text

Abstract:

724 Background: Perioperative chemotherapy with single regimen either FOLFIRINOX (FFX) or gemcitabine/nab-paclitaxel (Gem/NabP) is the current standard of care for pancreatic and periampullary cancers (PC) with overall survival (OS) of 2-3 years without pre-selected CA19-9 level. Sequential chemotherapy with FFX plus Gem/NabP has recently been investigated in metastatic PC and shown to improve OS. We investigated the outcome of patients who received sequential perioperative chemotherapy FFX plus Gem/NabP. Methods: Patients treated with curative intent surgery for PC who received perioperative

APA, Harvard, Vancouver, ISO, and other styles

22

Prashanth, M. K., M. Madaiah, H. D. Revanasiddappa, and K. N. Amruthesh. "Synthesis, Characterization, and BSA Binding Studies of Some New Benzamides Related to Schiff Base." ISRN Organic Chemistry 2013 (April 7, 2013): 1–12. http://dx.doi.org/10.1155/2013/791591.

Full text

Abstract:

Condensation of amine 1 with aldehyde 2 gives Schiff base, N-(4-((benzofuran-2-ylmethylene) amino)phenyl)acetamide 3. Schiff base on N-acylation with different substituted acid chlorides in the presence of triethylamine gives the corresponding benzamides, N-acetyl-N-(4-((benzofuran-2-ylmethylene)amino)phenyl)substitutedbenzamide (NABP) 5a–j. The structures of newly synthesized compounds were characterized by elemental analysis, 1H NMR, 13C NMR FT-IR, and mass spectral studies. Compounds 3 and 5a–j have been screened for their antimicrobial activity using the disc diffusion and minimum inhibito

APA, Harvard, Vancouver, ISO, and other styles

23

Hussein, Maen A., Gazala Khan, Sreenivasa R. Chandana, et al. "NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naïve patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Updated overall survival analysis with 29-month follow-up of NAPOLI 3." Journal of Clinical Oncology 42, no. 16_suppl (2024): 4136. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.4136.

Full text

Abstract:

4136 Background: NAPOLI 3 (NCT04083235, N = 770), a global, randomized, open-label phase 3 study, demonstrated that NALIRIFOX significantly improved overall survival (OS, primary endpoint) and progression-free survival compared with nab-paclitaxel and gemcitabine in patients with untreated mPDAC. Here, we report an updated analysis of OS. Methods: Eligible patients with histopathologically/cytologically confirmed untreated mPDAC were randomized (1:1) to receive liposomal irinotecan 50 mg/m2 + oxaliplatin 60 mg/m2 + leucovorin 400 mg/m2 + 5-fluorouracil 2400 mg/m2 (NALIRIFOX, n = 383) on days 1

APA, Harvard, Vancouver, ISO, and other styles

24

Amis, Debby. "Commentary on the Consensus Statement—Kudos to American Midwives." Journal of Perinatal Education 22, no. 1 (2013): 19–20. http://dx.doi.org/10.1891/1058-1243.22.1.19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Raedels, Alan. "Forecasting the NAPM Purchasing Managers' Index." Journal of Purchasing and Materials Management 26, no. 4 (1990): 34–39. http://dx.doi.org/10.1111/j.1745-493x.1990.tb00519.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

D., Y. M. "Le virus Zika à la NABM." Option/Bio 28, no. 567-568 (2017): 5. http://dx.doi.org/10.1016/s0992-5945(17)30183-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Kang, Beom-Goo, Nabendu B. Pramanik, Nikhil K. Singha, Jae-Suk Lee, and Jimmy Mays. "Precise synthesis of thermoreversible block copolymers containing reactive furfuryl groups via living anionic polymerization: the countercation effect on block copolymerization behavior." Polymer Chemistry 6, no. 37 (2015): 6732–38. http://dx.doi.org/10.1039/c5py00983a.

Full text

Abstract:

Well-defined block copolymers containing furan groups were anionically synthesized in the presence of NaBPh<sub>4</sub> and used for the formation of thermoreversible networks via a Diels–Alder click reaction.

APA, Harvard, Vancouver, ISO, and other styles

28

Kretzschmar, Alexander. "Metastasiertes Mammakarzinom: Wöchentliches nabTM-Paclitaxel bewirkt längeres Gesamtüberleben." Onkologische Welt 03, no. 01 (2012): 29. http://dx.doi.org/10.1055/s-0038-1631068.

Full text

Abstract:

Die wöchentliche Gabe von 150 mg/m2 nab™-Paclitaxel (Abraxane®) kann das Gesamtüberleben in der Erstlinienbehandlung des metastasierten Mammakarznioms im Vergleich zu bisherigen Taxan-Monotherapien verlängern. Patientinnen, bei denen diese Dosis reduziert werden musste, erreichten durch eine im Median um zwei Zyklen verlängerte Behandlungsdauer ein vergleichbares progressionsfreies und Gesamtüberleben, wie Patientinnen ohne Dosisreduktion. Dies ergab eine multizentrische Phase- II-Studie, die auf dem SABCS 2011 vorgestellt wurde.

APA, Harvard, Vancouver, ISO, and other styles

29

PEREZRUIZ, T., C. MARTINEZLOZANO, V. TOMAS, and R. CASAJUS. "Flow-injection fluorimetric determination of nabam and metham." Talanta 43, no. 2 (1996): 193–98. http://dx.doi.org/10.1016/0039-9140(95)01714-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

P., S. Nikam, P. Shewale R., B. Sawant A., and Hasan Mehdi. "Viscometric studies of cesium halides, (C4H9)4NBr, NaBr and NaBPh4 in aqueous acetone at 298.15 K." Journal of Indian Chemical Society Vol. 82, Jan 2005 (2005): 36–38. https://doi.org/10.5281/zenodo.5823816.

Full text

Abstract:

P. G. Department of Physical Chemistry, M.S. G. College, Malegaon Camp.-423 105, India <em>E-mail</em> : mihasan@rediffmail.com Arts, Science and Commerce College. Nampur-423 204, India <em>Manuscript received 19 January 2004, revised 27 May 2004, accepted 22 July 2004</em> The viscosities of cesium halides (CI<sup>-</sup>, Br<sup>-</sup> and I<sup>-</sup>), (C<sub>4</sub>H<sub>9</sub>)<sub>4</sub> NHr, NaBr and NaBPh<sub>4</sub> have been measured in (0, 20, 40, 80) mass% aqueous acetone at 298.15 K. The viscosity <em>B</em>-coefficients have been calculated by using the Jones-Dole equation.

APA, Harvard, Vancouver, ISO, and other styles

31

Corrie, Philippa, Wendi Qian, Bristi Basu, et al. "A randomized phase II trial comparing different schedules of nab-paclitaxel (nabP) combined with gemcitabine (GEM) as first line treatment for metastatic pancreatic adenocarcinoma (mPDAC)." Journal of Clinical Oncology 35, no. 15_suppl (2017): 4100. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.4100.

Full text

Abstract:

4100 Background: NabP+GEM chemotherapy improves survival compared with GEM monotherapy as treatment for mPDAC. A PDAC mouse model suggested that nabP potentiates GEM activity by reducing cytidine deaminase levels and scheduling may be critical to optimise clinical benefit. Methods: Patients (pts) were randomised to receive standard concomitant (CON) nabP+GEM or sequential (SEQ) administration, with nabP given 24 hours before GEM. After 6 cycles, pts benefiting from treatment could continue the same regimen until disease progression. The primary endpoint was progression-free survival (PFS) by R

APA, Harvard, Vancouver, ISO, and other styles

32

Yuan, Guo-Jun, Shao-Xian Liu, Zheng-Fang Tian, and Xiao-Ming Ren. "A high temperature reversible phase transition in a supramolecular complex of 15-crown-5 with tetraphenylboron sodium." New Journal of Chemistry 42, no. 18 (2018): 14943–48. http://dx.doi.org/10.1039/c8nj02754d.

Full text

Abstract:

High temperature (391 K) reversible phase transition and large thermal hysteresis (19 K) was observed in 15-crown-5 clathrates: [Na(15-crown-5)][BPh<sub>4</sub>] (15-crown-5 = 1,4,7,10,13-pentaoxacyclopentadecane, NaBPh<sub>4</sub> = sodium tetraphenylboron).

APA, Harvard, Vancouver, ISO, and other styles

33

Cova, Dario, Pietro Fumagalli, and Angela Santagostino. "Toxicity of Ethylene-bis-dithiocarbamates (EBDCs) in a Human Neuroblastoma Cell Line." Alternatives to Laboratory Animals 19, no. 1 (1991): 39–40. http://dx.doi.org/10.1177/026119299101900108.

Full text

Abstract:

The aim of our research was the in vitro evaluation of the neurotoxic effects of three EBDCs (Nabam, Zineb and Maneb) and ETU on SK-N-BE human neuroblastoma cells as a model for neurotoxicity in humans. The EC50 value was used as an index of the toxicities of these compounds. Since Zineb and Maneb contain zinc and manganese as cations, respectively, in order to determine the contributions of these metals, the EC50s of zinc chloride and manganese chloride were also evaluated. Nabam, Zineb and Maneb had EC50 values ranging from 1μM to 30μM; the EC50s of manganese and zinc in this human cell line

APA, Harvard, Vancouver, ISO, and other styles

34

Manus, Jean-Marie. "Brève : Test salivaire Covid à la NABM." Revue Francophone des Laboratoires 2021, no. 531 (2021): 19. http://dx.doi.org/10.1016/s1773-035x(21)00097-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Parks, Robert E. "NAPM and Its Role in Optical Standards." Optics and Photonics News 3, no. 10 (1992): 66. http://dx.doi.org/10.1364/opn.3.10.000066.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

D, Y. M. "Dengue et chikungunya font évoluer la NABM." Option/Bio 25, no. 506 (2014): 5. http://dx.doi.org/10.1016/s0992-5945(14)71703-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Manus, Jean-Marie. "Brèves : Rougeole : du nouveau à la NABM." Revue Francophone des Laboratoires 2020, no. 518 (2020): 13. http://dx.doi.org/10.1016/s1773-035x(20)30016-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Traynor, Kate. "Tablet splitting, education on NABP delegates' minds." American Journal of Health-System Pharmacy 58, no. 15 (2001): 1390. http://dx.doi.org/10.1093/ajhp/58.15.1390.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Landis, Nancy Tarleton. "NABP addresses pain management, confidentiality, Y2K preparedness." American Journal of Health-System Pharmacy 56, no. 15 (1999): 1486. http://dx.doi.org/10.1093/ajhp/56.15.1486.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Landis, Nancy Tarleton. "NABP proposes national competence assessment for technicians." American Journal of Health-System Pharmacy 57, no. 13 (2000): 1204. http://dx.doi.org/10.1093/ajhp/57.13.1204.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Sobolev, A. V., P. G. Talabanov, G. V. Ryabykina, and E. Sh Kozhemyakina. "The relationship between the antihypertensive effect of b-adrenergic blockers and the initial daily variability of sinus rhythm." Systemic Hypertension 15, no. 4 (2018): 24–29. http://dx.doi.org/10.26442/2075082x.2018.4.000029.

Full text

Abstract:

The objective of rhe study was to identify the features of the daily sinus rhythm variability (HRV), affecting the manifestations of the antihypertensive effect of b-adrenergic blockers and to establish the connection of this effect with the dynamics of the daily HRV. Material and methods. 52 patients with grade 1-2 degree essential arterial hypertension (32 to 60 years old - 21 men and 31 women) underwent general clinical and functional examination using bifunctional monitoring of ECG and blood pressure before and after treatment with carvedilol, nebivolol and bisoprolol. Monitor daily mean s

APA, Harvard, Vancouver, ISO, and other styles

42

Armstrong, Elizabeth Mitchell. "Commentary on the Consensus Statement—Centering the Norm: Let’s Make “Normal Birth” Usual Again." Journal of Perinatal Education 22, no. 1 (2013): 21–22. http://dx.doi.org/10.1891/1058-1243.22.1.21.

Full text

Abstract:

In this column, Elizabeth Mitchell Armstrong provides expert commentary on the article “Supporting Healthy and Normal Physiologic Childbirth: A Consensus Statement by ACNM, MANA, and NACPM.” The consensus statement on normal physiologic birth points the way to recenter social norms and expectations around birth.

APA, Harvard, Vancouver, ISO, and other styles

43

Wainberg, Zev A., Davide Melisi, Teresa Macarulla, et al. "NAPOLI-3: A randomized, open-label phase 3 study of liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-naïve patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)." Journal of Clinical Oncology 41, no. 4_suppl (2023): LBA661. http://dx.doi.org/10.1200/jco.2023.41.4_suppl.lba661.

Full text

Abstract:

LBA661 Background: Liposomal irinotecan administered with 5-fluorouracil/leucovorin (5-FU/LV) is approved in the USA and Europe for mPDAC following progression with gemcitabine-based therapy. A phase 1/2 study (Wainberg et al. Eur J Cancer 2021;151:14–24; NCT02551991) demonstrated promising anti-tumor activity in patients with mPDAC who received first-line liposomal irinotecan 50 mg/m2 + 5-FU 2400 mg/m2 + LV 400 mg/m2 + oxaliplatin 60 mg/m2 (NALIRIFOX). Herein, we present results from NAPOLI-3 (NCT04083235), a randomized, open-label, phase 3 study investigating the efficacy and safety of NALIR

APA, Harvard, Vancouver, ISO, and other styles

44

Seufferlein, Thomas, Antonio Cubillo Gracian, and Marc Kueng. "PANOVA-4 (EF-39): Pilot study of tumor treating fields (TTFields) therapy with atezolizumab, gemcitabine (GEM), and nab-paclitaxel (NabP) as first-line (1L) treatment for metastatic pancreatic ductal adenocarcinoma (mPDAC)." Journal of Clinical Oncology 42, no. 3_suppl (2024): TPS718. http://dx.doi.org/10.1200/jco.2024.42.3_suppl.tps718.

Full text

Abstract:

TPS718 Background: TTFields are electric fields that exert physical forces to disrupt cellular processes critical for cancer cell viability and tumor progression. TTFields therapy is noninvasive, locoregional, and is delivered via a portable electric field generator and skin-placed arrays. TTFields therapy has low risk of systemic toxicity and is approved for glioblastoma (and grade 4 glioma in Europe), and pleural mesothelioma. In vitro, TTFields (150 kHz) application decreased pancreatic cancer cell proliferation and clonogenicity; in vivo, TTFields concomitant with chemotherapy (chemo) had

APA, Harvard, Vancouver, ISO, and other styles

45

Chen, Lanlan, Shuai Xu, Wei Li, et al. "Tumor-acidity activated surface charge conversion of two-photon fluorescent nanoprobe for enhanced cellular uptake and targeted imaging of intracellular hydrogen peroxide." Chemical Science 10, no. 40 (2019): 9351–57. http://dx.doi.org/10.1039/c9sc03781k.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Manji, Gulam, Nathan Bahary, Vincent Chung, et al. "259 Phase Ib/II open-label, randomized evaluation of atezolizumab (atezo) + selicrelumab (seli) + gemcitabine+nab-paclitaxel (gem+nabP) or bevacizumab (bev) vs control in MORPHEUS-PDAC, -TNBC and -CRC." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (2020): A283. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0259.

Full text

Abstract:

BackgroundThe MORPHEUS platform comprises multiple randomized Phase Ib/II trials to identify early safety and efficacy signals for treatment combinations across cancers. Seli interacts with CD40 on antigen presenting cells, resulting in activation and priming of CD8 T-cells. Atezo (anti-PD-L1)+seli (CD40 agonist) was evaluated with gem+nabP for pancreatic ductal adenocarcinoma (PDAC), or with bev for triple-negative breast cancer (TNBC) and colorectal cancer (CRC).MethodsMORPHEUS-PDAC, MORPHEUS-TNBC and MORPHEUS-CRC enrolled 1L metastatic (m) PDAC, 2L locally advanced or mTNBC or 3L mCRC patie

APA, Harvard, Vancouver, ISO, and other styles

47

Kan, Tal, Tharwat Haj Khalil, Yiftah Barsheshet, et al. "Abstract 2176: Tumor treating fields (TTFields) together with gemcitabine and nab-paclitaxel (Gem/NabP) are effective against pancreatic ductal adenocarcinoma (PDAC), in vitro and in vivo." Cancer Research 85, no. 8_Supplement_1 (2025): 2176. https://doi.org/10.1158/1538-7445.am2025-2176.

Full text

Abstract:

Abstract Background: Tumor treating fields (TTFields) are a cancer therapy, approved for the treatment of glioblastoma, pleural mesothelioma, and non-small cell lung cancer (NSCLC). The efficacy and safety of TTFields concomitant with standard-of-care gemcitabine and nab-paclitaxel (Gem/NabP) are currently being tested in a phase 3 trial as front-line treatment for locally advanced pancreatic ductal adenocarcinoma (PDAC). TTFields are electric fields that disrupt critical cellular processes and induce immunogenic cell death (ICD) in cancer cells. They have also been shown to elicit a systemic

APA, Harvard, Vancouver, ISO, and other styles

48

Kauffman, Ralph G. "Indicator Qualities of the NAPM Report On BusinessR." Journal of Supply Chain Management 35, no. 2 (1999): 29–37. http://dx.doi.org/10.1111/j.1745-493x.1999.tb00234.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Jin, Yi, Arlène Roland, Wenqiang Zhou, Michelle Fauchon, Japhet Lyaku, and Radhakrishnan P. Iyer. "Synthesis and antiviral evaluation of nucleic acid-based (NABTM) libraries." Bioorganic & Medicinal Chemistry Letters 10, no. 17 (2000): 1921–25. http://dx.doi.org/10.1016/s0960-894x(00)00373-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Corrie, Philippa, Wendi Qian, Bristi Basu, et al. "A randomized phase II trial comparing different schedules of nab-paclitaxel (nabP) combined with gemcitabine (GEM) as first line treatment for metastatic pancreatic adenocarcinoma (PDAC)." Journal of Clinical Oncology 35, no. 4_suppl (2017): 342. http://dx.doi.org/10.1200/jco.2017.35.4_suppl.342.

Full text

Abstract:

342 Background: NabP+GEM chemotherapy improves survival compared with standard GEM monotherapy as treatment for advanced PDAC. A PDAC mouse model showed that delivery of nabP prior to GEM generated a higher intratumoural dFdC:dFdU ratio, which correlated with improved outcome. Therefore, scheduling may be critical to optimise clinical benefit. Methods: Patients were randomised to receive nabP+GEM, either concomitantly (CON) or sequentially (SEQ), 24 hours apart. After 6 cycles, patients benefiting from treatment could continue the same regimen until disease progression. The primary endpoint wa

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!